Biohacking Market Size, Share Global Analysis Report, , 2021 – 2026

Industry Insights

[197+ Pages Report] The latest report published by Facts & Factors titled global biohacking market has a global perspective on the latter coupled with the market size, volume, drivers, and restraints to name a few. We estimate that the biohacking market will hold a value of USD 14.65 Billion in the year 2020 with a CAGR growth of 21.1% which was previously subjected at USD 65.4 Billion in the year 2026.

Market Overview

Biohacking is often referred to as DIY biology is the form of an extremely broad and subjective branch of biogenetics and bioengineering that deals with a wider range of activities ranging from performing scientific activities on yeast or other organisms for the purpose of tracking your own sleep and diet to name a few. The field of biohacking gives everyone – individuals, communities, and small organization groups the immense ability and potential in deconstructing and reconstructing biology by using simple assays and kits for achieving groundbreaking results while contributing toward a larger social cause.

Industry Growth Factors

The rising growth of the global biohacking market can be contributed to a number of factors such as  increased adoption of consumers towards biohacking products, increase disposable incomes, favorable government policies and regulations, increased private funding for the rising R&D development measures, and widened initiatives by the key players to name a few. Furthermore, increased focus of biohackers in developing a strong and sustainable immunity system and supporting products will increase the footprint of the global biohacking market during the advent of the forecast in times of this ongoing pandemic. Moreover, increased activities for rolling out a vaccine being approved by global organization pertaining to biohacking related solutions will open new market revenue for the global biohacking market during the forecast duration.

Increasing experiments that stage extraordinary results for developing a better social frontier and message is expected to push the market toward a positive outlook. Rising consumer awareness coupled with increasing government involvement ensures consumer safety that will further propel the market potential for the global biohacking market to a higher standard of revenue. others factors such as lesser funding required by start-ups and an over low operational budget will further increase the horizon of the global biohacking market during the forecast. However, such activities and experiments are not regularly funded through government and standardized formats of funding and rely on other sources for passive sources of income for functioning. This factor is expected to hamper the market growth by a certain extent.

Segmentation Analysis

The global biohacking market can be segmented across products, applications, end-users, and regions.

The global biohacking market can be divided across wearables, implants, gene modification kits, smart drugs, supplements, mobile applications, and others on the basis of products. Wearables can be further segmented into smartwatches, patches, and smart rings, and so on. The wearables segment is expected to occupy the largest market share during the advent of the forecast owing to the rising focus of key players on the particular segment coupled with rising product demand due to optimal pricing solutions. The global biohacking market can be broken down into monitoring, treatment, research, and others on the basis of applications. Monitoring is expected to hold the largest market share during the advent of the forecast with recent trends indicating more than 30% of the latest market occupancy. The current market dominance can be credited to the increasing use of wearables and implants coupled with the rising number of mobile applications extending a wider array of support and functionality. The treatment segment will account for the fastest growing CAGR during the advent of the forecast. The global biohacking market can be disintegrated into pharmaceutical & biotechnology companies, hospitals & clinics, forensic laboratories, research & academic institutes, and others. The hospitals and clinics segment is likely to dominate the segment owing to the current trends indicating more than 20% of the current market iteration. Factors that can be credited to the market growth include increasing prevalence of chronic and infectious diseases coupled with a variable increase for monitoring devices to name a few. The other segment is expected to witness the fastest growing CAGR during the advent of the forecast owing to the rising adoption of biohacking products by individual players and vendors coupled with a phenomenal rise of the pharmaceutical sector during the forecast duration.

Regional Analysis

North America is expected to witness the largest market share during the advent of the forecast with current trends indicating more than 35% of the current market forecast. The key factors that can be credited to the dominant market position of the biohacking market in the region can be attributed to the rising research and development activities by government bodies coupled with increased integration of novel products in a wider variety of treatment solutions. Furthermore, factors such as increased adoption of technologies pertaining to synthetic biology will further bolster the market growth in the region to an increased foothold. Asia-Pacific is expected to witness the fastest growing CAGR during the advent of the forecast owing to the rising presence of technologically advanced healthcare infrastructure coupled with loosening government measures regarding biohacking measures.

Report Scope

Competitive Players

The key market participants for the global biohacking market are :

• Apple Inc.
• The ODIN
• Thync Global Inc.
• Fitbit Inc.
• Moodmetric
• HVMN Inc.
• Muse (Interaxon Inc.)
• Thriveport LLC
• TrackMyStack
• OsteoStrong
• Grindhouse Wetware
• SynBioBeta LLC

By Product Segment Analysis

• Wearables
• Implants
• Gene Modification Kits
• Smart Drugs
• Supplements
• Mobile Applications
• Others

By Application Segment Analysis

• Monitoring
• Treatment
• Research
• Others

By End-Users Segment Analysis

• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Forensic Laboratories
• Research & Academic Institutes
• Others

By Regional Segment Analysis

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of MEA